Literature DB >> 19333122

Improving the outcome of neonatal meningitis.

Eva P Galiza1, Paul T Heath.   

Abstract

PURPOSE OF REVIEW: Neonatal meningitis is an important cause of mortality and morbidity worldwide, and although mortality has declined in developed countries over the last two decades, improvement in morbidity has been less evident. This review focuses on recent advances in the management of neonatal meningitis and its implications for improved outcomes. RECENT
FINDINGS: Recent surveillance studies of neonatal meningitis have provided important information regarding the pathogens causing meningitis, their antibiotic-susceptibility profiles and their outcomes. Data supporting the importance of early recognition of the signs of neonatal meningitis, the early diagnosis of the causative pathogen, early and aggressive fluid therapy and supportive care and on the effect of adjunctive therapies on outcome measures are all largely theoretical or derived from paediatric and adult sepsis studies.
SUMMARY: There is likely to be considerable scope for improving the outcome from neonatal meningitis but more studies are required to define key interventions and to demonstrate their effectiveness.

Entities:  

Mesh:

Year:  2009        PMID: 19333122     DOI: 10.1097/QCO.0b013e32832ad49e

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  12 in total

Review 1.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

2.  Evaluation of a chromogenic agar for detection of group B streptococcus in pregnant women.

Authors:  Robin R Craven; Carol J Weber; Rebecca A Jennemann; W Michael Dunne
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

3.  Administration of capsule-selective endosialidase E minimizes upregulation of organ gene expression induced by experimental systemic infection with Escherichia coli K1.

Authors:  Andrea Zelmer; Melissa J Martin; Ozan Gundogdu; George Birchenough; Rebecca Lever; Brendan W Wren; J Paul Luzio; Peter W Taylor
Journal:  Microbiology (Reading)       Date:  2010-04-15       Impact factor: 2.777

Review 4.  Bacterial meningitis in infants.

Authors:  Lawrence C Ku; Kim A Boggess; Michael Cohen-Wolkowiez
Journal:  Clin Perinatol       Date:  2014-12-06       Impact factor: 3.430

5.  Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis.

Authors:  Cornelia Blaser; Matthias Klein; Denis Grandgirard; Matthias Wittwer; Heikki Peltola; Michael Weigand; Uwe Koedel; Stephen L Leib
Journal:  BMC Infect Dis       Date:  2010-03-30       Impact factor: 3.090

Review 6.  Microglia in infectious diseases of the central nervous system.

Authors:  Monica M Mariani; Tammy Kielian
Journal:  J Neuroimmune Pharmacol       Date:  2009-09-02       Impact factor: 4.147

7.  Neonatal meningitis associated with osteomyelitis and epidural empyema.

Authors:  Beatriz Vale; Sofia Morais; Cristina Resende; Adelaide Taborda
Journal:  BMJ Case Rep       Date:  2013-08-23

8.  Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems.

Authors:  Yung-Chi Chang; Zhipeng Wang; Lindsay A Flax; Ding Xu; Jeffrey D Esko; Victor Nizet; Miriam J Baron
Journal:  PLoS Pathog       Date:  2011-06-23       Impact factor: 6.823

9.  Infections of the nervous system.

Authors:  Vevek Parikh; Veronica Tucci; Sagar Galwankar
Journal:  Int J Crit Illn Inj Sci       Date:  2012-05

10.  CTX-M beta-lactamase production and virulence of Escherichia coli K1.

Authors:  Damien Dubois; Nemani V Prasadarao; Rahul Mittal; Laurent Bret; Marie Roujou-Gris; Richard Bonnet
Journal:  Emerg Infect Dis       Date:  2009-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.